Invitrogen

Companies Invitrogen

News Invitrogen

• Selvita Appoints Piotr Prelich as a Vice President of Sales and Marketing

  Selvita announced the appointment of Mr. Piotr Prelich to the position of Vice President of Sales and Marketing. Mr. Prelich will be responsible for the further establishment of Selvita’s brand in the pharmaceutical preclinical outsourcing market, both in Poland and abroad, as well as for the sales more

• Invitrogen Announces Opening of Hepatocyte Supply Facility in Warrington, UK

  Invitrogen, part of Life Technologies Corporation, announced the opening of a new facility in Warrington, UK, which will supply freshly isolated human hepatocytes to researchers in Europe. Human hepatocytes isolated from liver tissue are used for many biopharmaceutical applications, by researchers more

• Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

  Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint venture p more

White papers Invitrogen

• Analysis of Prostate Tumour Cell Invasion Using BD FluoroBlokTMand FLUOstar OPTIMA
  

  The FLUOstar OPTIMA is used for reading the BD Biosciences FluoroBlok(TM) tumour cell invasion system. In this application note we show that the results are comparable to the traditional invasion assays. The introduced method is fast, saving time and labour. The FLUOstar OPTIMA is able to take multiple readings over time at a user defined temperature more

• Superior Transfection of Human Embryonic Stem Cells with FuGENE® HD Transfection Reagent
  

  Gene manipulation techniques are potentially powerful tools in many applications for human embryonic stem (ES) cell research. Controlling expression levels of specific genes may improve the efficiency of differentiation induction. Cell types of interest may be collected using marker genes and antibiotic resistance genes. Tracking of ES cells derived after engraftment could be facilitated by tracer genes. It may also be possible to selectively destroy transplanted cells. more

• Molecular Probes® NanoOrange® Assay Performed on BMG LABTECH FLUOstar OPTIMA Microplate Reader
  

  The field of proteomics has expanded dramatically in recent years with research on a whole host of organisms. Techniques such as two dimensional difference gel electrophoresis (2D DIGE) require the accurate quantitation of protein, as up to three labelled samples can be loaded on a single gel for comparison. Assay methods for determining protein quantitation include absorbance at 280 nm(1), the Bradford assay(2), Lowry assay(3), BCA method(4) and more sensitive assays such as Fluoroprofile® (Sigma-Aldrich) and NanoOrange® (Molecular Probes®)5(). more

Publications Invitrogen

• A Rapid Western Blotting Protocol for the Xenopus Oocyte

  Often experimentalists require a quantitative assessment of the levels of heterologously expressed proteins to best interpret changed Ca2+ signaling patterns. Here, we detail a rapid and convenient western blotting method for individual Xenopus oocytes. The method exploits recently introduced rapid more

• Labeling DNA (or RNA) for Single-Molecule FRET

  Single-molecule (sm) fluorescence detection is a powerful method for studying biological events without time and population averaging. Förster (fluorescence) resonance energy transfer (FRET) is a spectroscopic technique for measuring distances in the 30–80 Å range in which excitation energy of a do more

• Labeling Mitochondria with MitoTracker Dyes

  INTRODUCTION Membrane-potential-dependent dyes such as Rhodamine 123, tetramethylrhodamine methyl ester (TMRM), and tetramethylrhodamine ethyl ester (TMRE) are useful as long as the mitochondrion maintains its negative membrane potential. MitoTracker is a commercially available fluorescent dye (Inv more

Market studies Invitrogen

• Stem Cell Technologies: World Market Outlook 2011-2021

  How will the stem cells market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021. This report covers stem cells in therapeutic applications: technologies, products and services. You will assess events, opportunities and activities more

• RNAi for Therapeutic Applications: Market Prospects 2011-2021

  How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. You will see the commercial prospects for RNAi-based therapeutics. We aim to save you time and aid your decisions through our research, dat more

Websites Invitrogen